Best candidates for dopamine agonist withdrawal in patients with prolactinomas.

Myoung Jin JiJung Hee KimJi Hyun LeeJung Hyun LeeYong Hwy KimSun Ha PaekChan Soo ShinSeong Yeon Kim

Published in: Pituitary (2018)

Patients who have no tumor visible on MRI, have a nadir PRL level <1 ng/dL during drug treatment, and received drug treatment for >6 years may be the best candidates for DA withdrawal.

Keyphrases

end stage renal disease
magnetic resonance imaging
chronic kidney disease
ejection fraction
newly diagnosed
computed tomography
combination therapy
uric acid